# A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear

> **NCT06414005** · PHASE2,PHASE3 · RECRUITING · sponsor: **Tego Science, Inc.** · enrollment: 166 (estimated)

## Conditions studied

- Partial Thickness Rotator Cuff Tear

## Interventions

- **BIOLOGICAL:** TPX-115
- **OTHER:** Placebo (Saline)

## Key facts

- **NCT ID:** NCT06414005
- **Lead sponsor:** Tego Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-15
- **Primary completion:** 2026-06-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 166 (ESTIMATED)
- **Last updated:** 2024-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06414005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06414005, "A Phase 2b/3 Study of TPX-115 on Partial-thickness Rotator Cuff Tear". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06414005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*